Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchangeMark Keegan, Claudia F. Lucchinetti, Andreas Bitsch et al.|The Lancet|2005Cited by 430
Switching from natalizumab to fingolimodLudwig Kappos, Athanasios P. Kyritsis, Ernst‐Wilhelm Radue et al.|Neurology|2015Cited by 116